Vapi: Abu Dhabi Investment Authority (ADIA), the UAE’s largest sovereign wealth fund, has signed a definitive agreement to acquire a 3% stake in Meril (Micro Life Sciences), a medical devices manufacturer, for $200 million (approximately Rs 1,700 crore).

ADIA, in an official statement, said: “A wholly owned subsidiary of the Abu Dhabi Investment Authority has entered into definitive agreements to invest USD 200 million for an approximately 3% stake in Micro Life Sciences Private Limited, one of India’s leading medical devices companies. This investment values Meril at an enterprise value of USD 6.6 billion.”

The transaction is subject to regulatory approval by the Competition Commission of India (CCI).

Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a focus on clinically advanced solutions across multiple specialties, including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical robotics.

“This investment by ADIA reinforces confidence in Meril’s long-term vision and global ambitions. It will help us accelerate growth, attract top talent, and further enhance our R&D and clinical research as we work to improve the quality of human life through advanced healthcare solutions,” said Sanjeev Bhatt, senior vice president – strategy at Meril. DeshGujarat